Bladder cancer secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{F.K}} | {{CMG}} {{AE}} {{F.K}} | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of bladder cancer include early screening and early intervention of treatment. | Effective measures for the secondary prevention of bladder cancer include early [[screening]] and early intervention of treatment. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Effective measures for the secondary prevention of bladder cancer include:<ref name="pmid16413099">{{cite journal |vauthors=Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ |title=Prevention of bladder cancer: a review |journal=Eur. Urol. |volume=49 |issue=2 |pages=226–34 |date=February 2006 |pmid=16413099 |doi=10.1016/j.eururo.2005.12.011 |url=}}</ref><ref name="pmid27000312">{{cite journal |vauthors=Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP |title=Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses |journal=Eur. J. Epidemiol. |volume=31 |issue=9 |pages=811–51 |date=September 2016 |pmid=27000312 |pmc=5010611 |doi=10.1007/s10654-016-0138-6 |url=}}</ref> | *Effective measures for the secondary [[prevention]] of bladder cancer include:<ref name="pmid16413099">{{cite journal |vauthors=Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ |title=Prevention of bladder cancer: a review |journal=Eur. Urol. |volume=49 |issue=2 |pages=226–34 |date=February 2006 |pmid=16413099 |doi=10.1016/j.eururo.2005.12.011 |url=}}</ref><ref name="pmid27000312">{{cite journal |vauthors=Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP |title=Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses |journal=Eur. J. Epidemiol. |volume=31 |issue=9 |pages=811–51 |date=September 2016 |pmid=27000312 |pmc=5010611 |doi=10.1007/s10654-016-0138-6 |url=}}</ref> | ||
**Early screening | **Early [[screening]] | ||
**Early intervention of treatment | **Early intervention of treatment | ||
***Immunotherapy | ***[[Immunotherapy]] | ||
***Radation therapy | ***Radation therapy | ||
***Chemotherapy | ***[[Chemotherapy]] | ||
***Surgery | ***[[Surgery]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 14:48, 29 May 2018
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Bladder cancer secondary prevention |
|
Risk calculators and risk factors for Bladder cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Effective measures for the secondary prevention of bladder cancer include early screening and early intervention of treatment.
Secondary Prevention
- Effective measures for the secondary prevention of bladder cancer include:[1][2]
- Early screening
- Early intervention of treatment
- Immunotherapy
- Radation therapy
- Chemotherapy
- Surgery
References
- ↑ Leppert JT, Shvarts O, Kawaoka K, Lieberman R, Belldegrun AS, Pantuck AJ (February 2006). "Prevention of bladder cancer: a review". Eur. Urol. 49 (2): 226–34. doi:10.1016/j.eururo.2005.12.011. PMID 16413099.
- ↑ Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (September 2016). "Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses". Eur. J. Epidemiol. 31 (9): 811–51. doi:10.1007/s10654-016-0138-6. PMC 5010611. PMID 27000312.